Please Wait.....
Report
Laboratoires Pierre Fabre SA - Strategic SWOT Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI's, and Recent Trends
Company Report I 2025-05-14 I 95 Pages I Quaintel Research
Report Summary
Laboratoires Pierre Fabre SA - Strategic SWOT Insights - A 360 Review of Opportunities, Challenges and Risk, Corporate and ESG Strategies, Competitive Intelligence and Operational KPI's, and Recent Trends is a comprehensive and easily accessible overview of Laboratoires Pierre Fabre SA 's business operations. It provides a detailed analysis of the company's strategic standing, as well as its position in the industry compared to competitors. The report includes several key features to facilitate decision-making and provide insights into the company's performance.
The report begins with in-depth information about Laboratoires Pierre Fabre SA including key insights, business segments, key executives, locations, products and services, historical events, corporate strategy, and management discussions. This section provides a solid foundation for understanding the company's key attributes.
Next, the report assesses Laboratoires Pierre Fabre SA's strategic standing through various analyses. The ESG spotlight evaluates the company's environmental, social, and governance performance, providing insights into its sustainability efforts and ethical practices. The SWOT analysis examines the company's internal strengths and weaknesses, as well as external opportunities and threats. By integrating these strategic analyses, the report offers a comprehensive understanding of Laboratoires Pierre Fabre SA's overall strategic standing and supports informed decision-making and strategic planning.
Finally, the report includes recent news and deal activities undertaken by Laboratoires Pierre Fabre SA enhancing awareness of the company's business trends, growth perspectives, and more.
Key Highlights
Laboratoires Pierre Fabre SA is a global pharmaceutical and dermo-cosmetics company dedicated to advancing health and well-being through innovation and high-quality products. Founded in 1962, the company has established itself as a leader in dermatology, oncology, and consumer health, offering a wide range of prescription medications, over-the-counter treatments, skincare, haircare solutions, and dietary supplements. With a strong commitment to research and development, Laboratoires Pierre Fabre SA continuously invests in new treatments and technologies to address the evolving needs of patients and consumers.
The company operates across multiple regions, with a strong presence in Europe, North America, and Asia, providing its products and services to millions worldwide. It also collaborates with healthcare professionals, researchers, and pharmaceutical partners to drive innovation in drug development and clinical research. Headquartered in Roubaix, France, Laboratoires Pierre Fabre SA integrates sustainability into its operations, ensuring that its products and practices contribute positively to both human health and the environment.
Laboratoires Pierre Fabre SA in the News:-
- 07-Oct-2024 - Pierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology.
- 21-Jun-2024 - Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO
- 12-Jun-2024 - " Green Bioplastics Project " wins 1st prize in the Maud Fontenoy Foundation
- 05-Jun-2024 - Pierre Fabre Laboratories Awarded Responsible Digital Label
- 21-May-2024 - Pierre Fabre Laboratories announce the submission by Atara Biotherapeutics of the biological license application for Tabelecleucel (Tab-cel) for the treatment of Epstein-Barr virus-associated positive post-transplant lymphoproliferative disease to the FDA (Food and Drug Administration) USA
Scope
- Tactical Analysis:- Various strategic frameworks to gain insights into a company's competitive position and operational environment. These analytical tools assist in identifying competitive advantages, potential risks, and areas for improvement and efficiency, enabling companies to make informed tactical decisions.
- Business Strategy:- Contributes to shaping the company's overall direction, goals, and decision-making processes, ensuring long-term success and alignment with stakeholder expectations.
- Company Fundamentals:- These fundamentals offer valuable insights into the company's history, operations, leadership, and geographical presence, aiding in a comprehensive understanding of the organization.
- Competitive Landscape:- An identification of the company's main competitors, providing insights into the competitive landscape it operates in.
Reasons to Buy
- Comprehensive Understanding of the Laboratoires Pierre Fabre SA's internal and external factors through SWOT analysis and Corporate Strategy.
- Strive Strategic Decision Making with various analyses and identifying potential customers and suppliers.
- Mitigate Risk with help of thorough analysis of internal and external factors. Furthermore, develop strategies and contingency plans to address these challenges and minimize their impact on business operations.
- Competitive Benchmarking will help to gain a competitive advantage by understanding industry trends, customer preferences, and best practices.
- Valuable insights from the report enable investors and partners to make informed decisions regarding potential Collaborations, Investments, or Partnerships with the company.
Additionally, available deep-dive analysis on the company Laboratoires Pierre Fabre SA:
- Laboratoires Pierre Fabre SA PESTLE Analysis
- Laboratoires Pierre Fabre SA Value Chain Analysis
- Laboratoires Pierre Fabre SA Porter's Five Forces Analysis
- Laboratoires Pierre Fabre SA VRIO Analysis
- Laboratoires Pierre Fabre SA BCG Analysis
- Laboratoires Pierre Fabre SA Segmentation, Targeting and Positioning (STP) Analysis
- Laboratoires Pierre Fabre SA Ansoff Matrix Analysis
Table of Contents
Table of Contents 2
Tables 5
Charts 6
Laboratoires Pierre Fabre SA - Key Company Facts 7
Laboratoires Pierre Fabre SA - Company Description 8
Laboratoires Pierre Fabre SA - Top Executives 9
Laboratoires Pierre Fabre SA - Top Executives Biographies 10
Laboratoires Pierre Fabre SA - Head Office & Locations 11
Head Office - Country 11
Key Subsidiaries 12
Key Joint Ventures 13
Laboratoires Pierre Fabre SA - Products and Services 14
Products 14
Services 15
Laboratoires Pierre Fabre SA - Historic Events 16
Laboratoires Pierre Fabre SA - Company's Management Discussion 17
Laboratoires Pierre Fabre SA - Company's Mission and Vision 18
Mission 18
Vision 18
Laboratoires Pierre Fabre SA - Corporate Strategy 19
Laboratoires Pierre Fabre SA - Business Description 22
Pharmaceutical Segment 23
Dermo-Cosmetics and Personal Care Segment 23
Consumer Health and Over-the-Counter OTC Segment 24
Pharmaceutical Manufacturing and Contract Services Segment 24
Laboratoires Pierre Fabre SA - ESG Spotlight 25
Environment 25
Social 26
Corporate Governance 26
Laboratoires Pierre Fabre SA - SWOT Analysis 27
Overview 27
Strengths 29
Weaknesses 32
Opportunities 33
Threats 35
Competing Players 37
Snapshot of Competing Players 38
Beiersdorf AG 38
Key Company Facts 38
Company Description 38
Key Financials 39
Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price) 39
Key Financial Ratio Analysis 44
L'Oreal SA 45
Key Company Facts 45
Company Description 45
Key Financials 46
Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price) 46
Key Financial Ratio Analysis 51
Novartis AG 52
Key Company Facts 52
Company Description 52
Novartis AG - SWOT Spotlight 53
Key Financials 55
Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price) 55
Key Financial Ratio Analysis 60
Sanofi S.A. 61
Key Company Facts 61
Company Description 61
Sanofi S.A. - SWOT Spotlight 62
Sanofi S.A. - PESTLE Spotlight 64
Key Financials 66
Share Price Trend - Jan-2024 to May-2025 (Average Share Closing Price) 66
Key Financial Ratio Analysis 71
Galderma SA 72
Key Company Facts 72
Company Description 72
Laboratoires Pierre Fabre SA - In the News 73
07-Oct-2024 - Pierre Fabre & Scorpion Therapeutics announce new Phase I/II clinical trial for an innovative treatment in oncology. 73
21-Jun-2024 - Pierre Fabre Laboratories receives the Galien International Prize for EBVALLO 75
12-Jun-2024 - " Green Bioplastics Project " wins 1st prize in the Maud Fontenoy Foundation 77
05-Jun-2024 - Pierre Fabre Laboratories Awarded Responsible Digital Label 79
10-Jan-2024 - Herve Hoppenot, Incyte CEO, is appointed on the Board of Pierre Fabre Laboratories 82
28-Sep-2023 - Pierre Fabre becomes the first international manufacturing group to be awarded the "Outstanding" level of the Responsibility Europe label delivered by AFNOR Certification 83
20-Jun-2023 - Pierre Fabre unveils its ALL project: the largest international dermatology database. 86
09-Jun-2023 - PIERRE FABRE INAUGURATES ITS NEW INNOVATION CENTER IN CHINA 88
12-Apr-2023 - Pierre Fabre announces the acquisition of MEME 89
Laboratoires Pierre Fabre SA - Key Deals 91
12-Jul-2024 - Pierre Fabre Laboratoires signs a sponsorship agreement with the IHU healthAge In Toulouse 91
Appendix 92
Definitions 92
SWOT Analysis 92
PESTLE Analysis 92
Value Chain Analysis 92
ESG Spotlight 92
Research Methodology 93
Disclaimer 94
Contact Us 94
Tables
Table 1: Laboratoires Pierre Fabre SA - Company Facts
Table 2: Laboratoires Pierre Fabre SA - Digital Presence
Table 3: Laboratoires Pierre Fabre SA - Top Executives
Table 4: Laboratoires Pierre Fabre SA - Top Executives Biographies
Table 5: Laboratoires Pierre Fabre SA - Subsidiaries
Table 6: Laboratoires Pierre Fabre SA - Key Joint Ventures
Table 7: Laboratoires Pierre Fabre SA - Products
Table 8: Laboratoires Pierre Fabre SA - Services
Table 9: Laboratoires Pierre Fabre SA - Historic Events
Table 10: Laboratoires Pierre Fabre SA - Competing Players
Table 11: Competing Players - Beiersdorf AG - Key Company Facts
Table 12: Beiersdorf AG - Share Price Trend - Jan-2024 to May-2025
Table 13: Competing Players - Beiersdorf AG - Profit and Loss Statement
Table 14: Beiersdorf AG - Balance Sheet 2021-2024
Table 15: Beiersdorf AG - Cash Flow Statement 2021-2024
Table 16: Beiersdorf AG - Ratio Analysis - 2021-2024
Table 17: Competing Players - L'Oreal SA - Key Company Facts
Table 18: L'Oreal SA - Share Price Trend - Jan-2024 to May-2025
Table 19: Competing Players - L'Oreal SA - Profit and Loss Statement
Table 20: L'Oreal SA - Balance Sheet 2021-2024
Table 21: L'Oreal SA - Cash Flow Statement 2021-2024
Table 22: L'Oreal SA - Ratio Analysis - 2021-2024
Table 23: Competing Players - Novartis AG - Key Company Facts
Table 24: Novartis AG - Share Price Trend - Jan-2024 to May-2025
Table 25: Competing Players - Novartis AG - Profit and Loss Statement
Table 26: Novartis AG - Balance Sheet 2021-2024
Table 27: Novartis AG - Cash Flow Statement 2021-2024
Table 28: Novartis AG - Ratio Analysis - 2021-2024
Table 29: Competing Players - Sanofi S.A. - Key Company Facts
Table 30: Sanofi S.A. - Share Price Trend - Jan-2024 to May-2025
Table 31: Competing Players - Sanofi S.A. - Profit and Loss Statement
Table 32: Sanofi S.A. - Balance Sheet 2021-2024
Table 33: Sanofi S.A. - Cash Flow Statement 2021-2024
Table 34: Sanofi S.A. - Ratio Analysis - 2021-2024
Table 35: Competing Players - Galderma SA - Key Company Facts
Charts
Figure 1: Laboratoires Pierre Fabre SA - SWOT Analysis
Figure 2: Beiersdorf AG - Average Share Price Trend - Jan-2024 to May-2025
Figure 3: Beiersdorf AG - Profit and Loss Statement - 2021-2024
Figure 4: Beiersdorf AG - Balance Sheet - 2021-2024
Figure 5: Beiersdorf AG - Cash Flow Statement 2021-2024
Figure 6: L'Oreal SA - Average Share Price Trend - Jan-2024 to May-2025
Figure 7: L'Oreal SA - Profit and Loss Statement - 2021-2024
Figure 8: L'Oreal SA - Balance Sheet - 2021-2024
Figure 9: L'Oreal SA - Cash Flow Statement 2021-2024
Figure 10: Competing Players - Novartis AG - SWOT Spotlight
Figure 11: Novartis AG - Average Share Price Trend - Jan-2024 to May-2025
Figure 12: Novartis AG - Profit and Loss Statement - 2021-2024
Figure 13: Novartis AG - Balance Sheet - 2021-2024
Figure 14: Novartis AG - Cash Flow Statement 2021-2024
Figure 15: Competing Players - Sanofi S.A. - SWOT Spotlight
Figure 16: Competing Players - Sanofi S.A. - PESTLE Spotlight
Figure 17: Sanofi S.A. - Average Share Price Trend - Jan-2024 to May-2025
Figure 18: Sanofi S.A. - Profit and Loss Statement - 2021-2024
Figure 19: Sanofi S.A. - Balance Sheet - 2021-2024
Figure 20: Sanofi S.A. - Cash Flow Statement 2021-2024
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security